ID: ALA388795

Max Phase: Preclinical

Molecular Formula: C42H76N12O11

Molecular Weight: 925.14

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O

Standard InChI:  InChI=1S/C42H76N12O11/c1-22(2)18-28(50-34(57)25(7)48-39(62)32-14-11-17-54(32)40(63)26(44)12-10-16-47-42(45)46)36(59)51-30(20-24(5)6)37(60)53-31(21-33(55)56)38(61)52-29(19-23(3)4)35(58)49-27(41(64)65)13-8-9-15-43/h22-32H,8-21,43-44H2,1-7H3,(H,48,62)(H,49,58)(H,50,57)(H,51,59)(H,52,61)(H,53,60)(H,55,56)(H,64,65)(H4,45,46,47)/t25-,26-,27-,28-,29-,30-,31-,32-/m0/s1

Standard InChI Key:  BJXCTJLBNRVYDL-ALERXTORSA-N

Associated Targets(non-human)

Hypothalamus (44 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 925.14Molecular Weight (Monoisotopic): 924.5757AlogP: -1.68#Rotatable Bonds: 30
Polar Surface Area: 383.45Molecular Species: ZWITTERIONHBA: 12HBD: 13
#RO5 Violations: 3HBA (Lipinski): 23HBD (Lipinski): 16#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.72CX Basic pKa: 11.55CX LogP: -5.94CX LogD: -6.41
Aromatic Rings: 0Heavy Atoms: 65QED Weighted: 0.02Np Likeness Score: 0.13

References

1. Rego JL, Leprince J, Luu-The V, Pelletier G, Tonon MC, Vaudry H..  (2007)  Structure-activity relationships of a series of analogs of the endozepine octadecaneuropeptide (ODN(11)(-)(18)) on neurosteroid biosynthesis by hypothalamic explants.,  50  (13): [PMID:17550241] [10.1021/jm0610548]

Source